Scholarly Index
Anne Blaes
University of Minnesota; 7,433 total citations; 328 total publications; best world rank #31
University of Minnesota
7,433Total citations
328Total publications
38H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 136 | US 77 | 96.78 |
| Cancer survivorship and care | Lifetime | 807 | US 372 | 95.71 |
| Economic and Financial Impacts of Cancer | Lifetime | 665 | US 423 | 93.80 |
| Cancer-related cognitive impairment studies | Lifetime | 457 | US 251 | 91.18 |
| Lymphatic Disorders and Treatments | Lifetime | 761 | US 286 | 58.14 |
| Cancer survivorship and care | 2021-2025 | 31 | US 13 | 98.71 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 54 | US 31 | 97.52 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 48 | US 24 | 95.84 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 444 | US 222 | 93.32 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 481 | US 185 | 93.65 |
| Cancer Treatment and Pharmacology | 2021-2025 | 438 | US 157 | 91.51 |
| Family Support in Illness | 2021-2025 | 334 | US 109 | 87.54 |
| Frailty in Older Adults | 2021-2025 | 820 | US 170 | 89.03 |
| Cancer-related cognitive impairment studies | 2021-2025 | 206 | US 94 | 86.84 |
| Cancer Risks and Factors | 2021-2025 | 462 | US 168 | 83.59 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 701 | US 252 | 71.95 |